Coronavirus Infections
Information
- Disease name
- Coronavirus Infections
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04312243 | Active, not recruiting | Phase 2 | NO Prevention of COVID-19 for Healthcare Providers | April 7, 2020 | April 7, 2023 |
| NCT05516459 | Active, not recruiting | Prospective Monitoring of BNT162b2 Second Vaccination Booster Effects in Health Care Workers (HCW) | January 6, 2022 | December 2023 | |
| NCT05354024 | Active, not recruiting | Phase 2/Phase 3 | Phase II/III Randomized Clinical Trial of Booster Dose of COVID-19 (Recombinant, Inactivated) Vaccine | February 28, 2023 | September 25, 2024 |
| NCT05033847 | Active, not recruiting | Phase 2 | Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cells) and Inactivated COVID-19 Vaccine (Vero Cells) in Population Aged 18 Years and Above | September 12, 2021 | January 2024 |
| NCT05982704 | Active, not recruiting | Phase 4 | Study of Tixagevimab/Cilgavimab and Regdanvimab Efficacy for Treatment of COVID-19 | August 18, 2022 | November 1, 2023 |
| NCT05655351 | Active, not recruiting | Early Phase 1 | Effect of a Vaccination Against COVID-19 on Monocyte Production of Oxygenated Derivatives. | December 21, 2022 | June 30, 2024 |
| NCT04305457 | Active, not recruiting | Phase 2 | Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19 | March 21, 2020 | April 2025 |
| NCT05548439 | Active, not recruiting | Phase 1 | Safety, Tolerability, and Immunogenicity of Trivalent Coronavirus Vaccine Candidate VBI-2901a | October 5, 2022 | February 2024 |
| NCT05726084 | Active, not recruiting | Phase 2/Phase 3 | Immunogenicity, Efficacy and Safety Trial of the Convacell Vaccine in Healthy Volunteers Aged 18 Years and Older | October 24, 2022 | December 30, 2023 |
| NCT05449405 | Completed | Phase 2/Phase 3 | Chlorpheniramine Nasal Spray to Accelerate COVID-19 Clinical Recovery in an Outpatient Setting: ACCROS-I | December 7, 2021 | March 11, 2022 |
| NCT04252885 | Completed | Phase 4 | The Efficacy of Lopinavir Plus Ritonavir and Arbidol Against Novel Coronavirus Infection | January 28, 2020 | May 31, 2020 |
| NCT04275414 | Completed | Phase 2 | Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia | February 15, 2020 | May 2, 2020 |
| NCT04308668 | Completed | Phase 3 | Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2 | March 17, 2020 | May 20, 2020 |
| NCT04321278 | Completed | Phase 3 | Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II) | March 28, 2020 | June 14, 2020 |
| NCT04322123 | Completed | Phase 3 | Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19) | April 1, 2020 | June 2, 2020 |
| NCT04322565 | Completed | Phase 2 | Colchicine Counteracting Inflammation in COVID-19 Pneumonia | April 20, 2020 | October 1, 2021 |
| NCT04323592 | Completed | Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome | March 23, 2020 | May 10, 2020 | |
| NCT04326309 | Completed | Audio Data Collection for Identification and Classification of Coughing | March 25, 2020 | January 24, 2022 | |
| NCT04328129 | Completed | N/A | Household Transmission Investigation Study for COVID-19 in Tropical Regions | March 23, 2020 | September 30, 2021 |
| NCT04336345 | Completed | Outcomes of Patients With COVID-19 in the Intensive Care Unit | April 1, 2020 | June 4, 2020 | |
| NCT04367740 | Completed | ScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19 | April 28, 2020 | February 28, 2022 | |
| NCT04383457 | Completed | Covid-19 Triage Using Camera-based AI | June 15, 2020 | October 8, 2020 | |
| NCT04394195 | Completed | sFlt1: a Biomarker of Organ Dysfunction in Critically-ill Patients With COVID-19? | April 3, 2020 | September 1, 2020 | |
| NCT04414618 | Completed | Phase 2 | A Study of Opaganib in Coronavirus Disease 2019 Pneumonia | July 2, 2020 | December 23, 2020 |
| NCT04420286 | Completed | Study of the Increase in ICU Beds Capacity During COVID-19 Pandemic in France | May 6, 2020 | June 12, 2020 | |
| NCT04424355 | Completed | Magnetic Resonance Imaging to Detect Signs of Viral Pneumonia in Patients With Coronavirus Infection. | May 19, 2020 | December 20, 2021 | |
| NCT04435106 | Completed | Compassionate Use of Opaganib in Patients With Coronavirus Disease 2019 (COVID-19) | April 3, 2020 | May 15, 2020 | |
| NCT04465552 | Completed | Arrhythmic Manifestations and Management in Hospitalized COVID-19 Patients | July 10, 2020 | January 24, 2021 | |
| NCT04553575 | Completed | CoViD-19 Patient in Reims University Hospital in March to April 2020 | September 25, 2020 | August 4, 2022 | |
| NCT04695301 | Completed | N/A | Functional Outcomes in COVID-19 Survivors and Use of a Digital Platform for Rehabilitation | July 1, 2020 | October 1, 2021 |
| NCT04993209 | Completed | Phase 1 | Clinical Trial of the COVID-19 Vaccine (Recombinant, Inactivated) in Brazil | July 9, 2021 | November 4, 2022 |
| NCT05046548 | Completed | Phase 1/Phase 2 | This is a Double-blind, Placebo-controlled, Randomized Study of the Tolerability, Safety and Immunogenicity of an Inactivated Whole Virion Concentrated Purified Vaccine (CoviVac) Against Covid-19 | October 3, 2020 | October 1, 2021 |
| NCT05047900 | Completed | N/A | The Impact of SARS-CoV-2 Rapid Antigen Testing Kit Screening in Bangkok Community | November 1, 2021 | January 13, 2023 |
| NCT05077930 | Completed | Phase 2 | Convalescent Plasma Therapy for Hospitalized Patients With COVID-19 | January 6, 2022 | April 7, 2022 |
| NCT05083039 | Completed | Observational Program, Study the Preventive Efficacy of the BiVac Polio Vaccine Against the Incidence of Acute Respiratory Infections, Including COVID-19 | May 14, 2020 | September 3, 2021 | |
| NCT05156723 | Completed | Phase 1/Phase 2 | Study of the Immunogenicity, Safety and Tolerability of the Convacell Vaccine. | July 19, 2021 | December 31, 2022 |
| NCT05244356 | Completed | N/A | Health Communication to Influence COVID-19 Vaccination Intent and Message Propagation | April 29, 2021 | June 7, 2021 |
| NCT02497885 | Completed | Seroprevalence of MERS-CoV IgG in Healthcare Workers | August 2015 | October 2015 | |
| NCT05800158 | Completed | Butterfly - Clinical Performance Study | April 12, 2023 | August 10, 2023 | |
| NCT05886829 | Completed | Phase 2/Phase 3 | Chlorpheniramine Nasal Spray to Accelerate COVID-19 Clinical Recovery in an Outpatient Setting: ACCROS-III | July 27, 2022 | February 1, 2023 |
| NCT05303155 | Recruiting | The Association of Gut Microbiota With COVID 19 Infection in Children | April 14, 2022 | December 31, 2024 | |
| NCT05407142 | Recruiting | Phase 3 | An Open Comprative Study of the Prophylactic Efficacy and a Non-comparative Study of the Immunogenicity and Safety of the Inactivated Whole-virion Concentrated Purified Coronavirus Vaccine (CoviVac) | July 7, 2021 | December 29, 2023 |
| NCT04262921 | Recruiting | French COVID Cohort | February 8, 2020 | August 7, 2025 | |
| NCT04318366 | Recruiting | COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor | March 19, 2020 | March 19, 2025 | |
| NCT04327570 | Recruiting | In-depth Immunological Investigation of COVID-19. | March 27, 2020 | March 30, 2026 | |
| NCT05069129 | Recruiting | Phase 1/Phase 2 | Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cells,NVSI-06-08) and Inactivated COVID-19 Vaccine (Vero Cells) in Population Aged 18 Years and Above | October 14, 2021 | February 2024 |
| NCT05599516 | Recruiting | Phase 3 | Recombinant COVID-19 Vaccine (CHO Cell, NVSI-06-09) Phase III Clinical Trial | November 4, 2022 | December 2023 |
| NCT04429594 | Recruiting | N/A | Study of the Incidence of SARS-CoV-2 Infection (COVID-19) | July 28, 2020 | December 31, 2025 |
| NCT04414631 | Terminated | Phase 2 | Conestat Alfa in the Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19 | August 6, 2020 | September 15, 2021 |
| NCT04341441 | Terminated | Phase 3 | Will Hydroxychloroquine Impede or Prevent COVID-19 | April 7, 2020 | December 15, 2020 |
| NCT04409873 | Terminated | Phase 2 | Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19) | March 31, 2021 | September 10, 2022 |
| NCT04365985 | Terminated | Phase 2 | Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19 | April 29, 2020 | April 1, 2021 |
| NCT04432272 | Terminated | Phase 2 | ANTIBODY-LEVEL BASED ANALYSIS OF COVID-19 CONVALESCENT SERUM (ABACCuS) | July 16, 2020 | November 28, 2020 |
| NCT04274322 | Unknown status | Identifying Critically-ill Patients With COVID-19 Who Will Benefit Most From Nutrition Support Therapy: Validation of the NUTRIC Nutritional Risk Assessment Tool | February 19, 2020 | July 2020 | |
| NCT05054075 | Unknown status | Phase 2 | Protocol Design for Evaluating the Immunity of Bivalve Fluids From Anodonta Cygnea in SARS and COVID-19 | October 1, 2021 | November 2022 |
| NCT05276388 | Unknown status | Establishment of a Biological Biobank of Subjects Vaccinated Against SARS-CoV-2 Infection (COVID-19) | January 1, 2021 | March 31, 2023 | |
| NCT05007457 | Unknown status | N/A | The Effectiveness of Respiratory Tele-rehabilitation After COVID-19 Pneumonia Related: a Randomized Controlled Trial | June 12, 2021 | June 12, 2023 |
| NCT04316728 | Unknown status | N/A | Clinical Performance of the VivaDiag ™ COVID-19 lgM / IgG Rapid Test in Early Detecting the Infection of COVID-19 | March 2020 | November 2020 |
| NCT04325919 | Unknown status | Coronavirus Disease 2019 (COVID-19) Study of Hospitalized Patients in Hong Kong | February 24, 2020 | June 17, 2023 | |
| NCT04307459 | Unknown status | Acute Respiratory Failure and COVID-19 in Real Life | March 19, 2020 | December 31, 2020 | |
| NCT04327349 | Unknown status | N/A | Investigating Effect of Convalescent Plasma on COVID-19 Patients Outcome: A Clinical Trial | March 28, 2020 | September 30, 2020 |
| NCT04412746 | Unknown status | Covid-19 and Diabetes in West of Algeria | April 1, 2020 | June 30, 2020 | |
| NCT04321174 | Unknown status | Phase 3 | COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir | April 17, 2020 | March 31, 2022 |
| NCT04322344 | Unknown status | Phase 2/Phase 3 | Escin in Patients With Covid-19 Infection | March 23, 2020 | December 30, 2020 |
| NCT04384458 | Unknown status | N/A | Comparative Study of Hydroxychloroquine and Ivermectin in COVID-19 Prophylaxis | July 20, 2020 | April 2021 |
| NCT05097677 | Unknown status | Follow-up of Covid-19 Long Term Sequelae | April 16, 2021 | July 16, 2023 | |
| NCT05331742 | Unknown status | Comparison of Clinical Outcome Among Vaccinated and Unvaccinated Coronavirus Disease Patients in Critical Care Unit. | April 15, 2022 | June 1, 2022 | |
| NCT04318314 | Unknown status | COVID-19: Healthcare Worker Bioresource: Immune Protection and Pathogenesis in SARS-CoV-2 | March 18, 2020 | April 30, 2022 | |
| NCT04594330 | Unknown status | Phase 2 | Virgin Coconut Oil (VCO) as a Potential Adjuvant Therapy in COVID-19 Patients | June 1, 2020 | December 31, 2020 |
| NCT05614245 | Withdrawn | Phase 1 | Safety, Tolerability, and Immunogenicity of Trivalent Coronavirus Vaccine Candidate VBI-2901e With E6020 Adjuvant | March 2023 | June 2024 |
| NCT04361461 | Withdrawn | Phase 3 | Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19) | April 30, 2020 | November 4, 2020 |
| NCT04290858 | Withdrawn | Phase 2 | Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID19 Infection | March 1, 2020 | February 1, 2022 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D018352